Haematology Blood Markers

Oxygen-carrying protein in red blood cells.

PED: AAS stimulate erythropoiesis (red blood cell production), increasing haemoglobin. This is a significant cardiovascular risk as high haemoglobin increases blood viscosity, raising stroke and heart attack risk. Values >180 g/L are concerning and warrant immediate intervention. EQ (Boldenone) is particularly notorious for raising haemoglobin.

Percentage of blood volume occupied by red blood cells.

PED: Directly related to haemoglobin. AAS increase haematocrit. Values >0.52 increase stroke and cardiovascular risk significantly. EQ (Boldenone) is particularly notorious for raising haematocrit.

Number of red blood cells per liter of blood.

PED: Increased by AAS-stimulated erythropoiesis. Follows haemoglobin and haematocrit trends.

Number of white blood cells. Important for immune function.

PED: Not typically significantly affected by AAS. Intense training can temporarily elevate. Low values may indicate overtraining or immune suppression.

Cell fragments essential for blood clotting.

PED: Generally not significantly affected by AAS. Monitor if using compounds that affect clotting or if taking aspirin/NSAIDs regularly.

Average size of red blood cells. Helps classify types of anemia.

PED: Not typically affected by AAS. Low MCV with low iron suggests iron deficiency from blood donations.

Average amount of haemoglobin per red blood cell.

PED: Not typically affected by AAS. Low MCH with low MCV suggests iron deficiency, common in athletes who donate blood regularly to manage high haematocrit.

Average concentration of haemoglobin in red blood cells.

PED: Not typically affected by AAS. Low MCHC can indicate iron deficiency. Useful alongside MCH and MCV to classify anaemia type.

Measures variation in red blood cell size. Elevated in mixed deficiency states.

PED: Can be elevated when iron is depleted from regular blood donations while AAS are stimulating new red blood cell production. A high RDW with normal MCV may indicate early iron deficiency.

Most abundant white blood cell type. First responders to bacterial infection.

PED: Can be transiently elevated after intense training. Chronic elevation may indicate infection or inflammation. Not typically directly affected by AAS.

White blood cells important for adaptive immunity (B cells, T cells, NK cells).

PED: Can be suppressed by overtraining or extreme caloric restriction during contest prep. Chronic low lymphocytes may indicate immune suppression.

White blood cells that differentiate into macrophages. Part of innate immunity.

PED: Not typically significantly affected by AAS. May be elevated with chronic inflammation or infection.

White blood cells involved in allergic responses and parasitic infections.

PED: Not typically affected by AAS. Elevation may indicate allergic reaction, parasitic infection, or certain medications.

Rarest white blood cell type. Involved in allergic and inflammatory responses.

PED: Not typically affected by AAS. Usually present in very small numbers. Rarely clinically significant in isolation.

Average size of platelets. Larger platelets are younger and more reactive. Can indicate bone marrow activity.

PED: Not directly affected by AAS. May increase when platelet turnover is high (e.g. from heavy training-induced microtrauma). Persistently elevated MPV with low platelets warrants investigation.

Immature red blood cells released from bone marrow. The absolute count is the most reliable indicator of bone marrow erythropoietic activity.

PED: AAS stimulate erythropoiesis via increased EPO production, suppressed hepcidin, and direct bone marrow stimulation — reticulocyte counts are typically elevated on cycle. Boldenone (EQ) has particularly marked erythropoietic effects. After blood donation (common for managing high haematocrit), reticulocytes spike within 3-6 days and normalise by 9-12 days. EPO use produces dramatic elevations — counts doubling from baseline is characteristic.

Percentage of immature granulocytes (metamyelocytes, myelocytes, promyelocytes) in peripheral blood. Normally near zero; elevation indicates bone marrow stimulation or infection.

PED: AAS stimulate granulopoiesis — stanozolol has been shown to accelerate neutrophil precursor maturation in bone marrow. EPO use stimulates broad haematopoiesis including granulocyte production. Intense training itself can cause transient elevation via exercise-induced bone marrow stimulation. Mild elevation (0.5-2%) is common in enhanced athletes and usually benign. Values >3% warrant investigation for infection or bone marrow pathology regardless of PED use.

Red blood cell precursors normally confined to bone marrow. Their presence in peripheral blood indicates severe erythropoietic stress, bone marrow pathology, or extramedullary haematopoiesis.

PED: EPO use and AAS-driven erythropoiesis can push NRBCs into peripheral blood, especially at high doses. High-dose testosterone, trenbolone, and equipoise (boldenone) are strongly erythropoietic. NRBCs are rare even in enhanced athletes — their presence at >1/100 WBC is always clinically significant and warrants investigation. Combined AAS + EPO use increases risk. Severe polycythaemia (HCT >54%) can be accompanied by NRBCs.